Clinical trial
Eight Weeks of Low Dose hCG Priming in Women With Diminished Ovarian Reserve Undergoing IVF/ICSI - a Randomized Controlled Trial
NCT07108621 is registered in ClinicalTrials.gov with Kristine Loessl as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Eight Weeks of Low Dose hCG Priming in Women With Diminished Ovarian Reserve Undergoing IVF/ICSI - a Randomized Controlled Trial
- Lead sponsor
- Kristine Loessl
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- January 25, 2026
- Completion date
- March 31, 2031
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
in vitro fertilization (ivf), infertility, female, ovarian reserve